RARA CRAFT DATABASE for FDA Medical Devices
510(k)K241605

FDA DEVICE FACTS

Adaptix™ PEEK Interbody System with Nanotechnology; Capstone Control™ PEEK Spinal System with Nanotechnology

Nanovis, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 5, 2024PRODUCT CODEMAX

Indications for use

The Adaptix™ PEEK Interbody System with Nanotechnology devices and the Capstone Control™ PEEK Spinal System with Nanotechnology devices including those with macro-, micro- and nano-roughened surface textured features are intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies) at one or two contiguous spinal levels from L2-S1. These patients should have had six months of nonoperative treatment. These patients may have had a previous non-fusion spinal surgery and/or may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved spinal level(s). Additionally, Adaptix™ PEEK Interbody System with Nanotechnology and the Capstone Control™ PEEK Spinal System with Nanotechnology devices can Nanovis Spine LLC be used as an adjunct to fusion in patients diagnosed with degenerative scoliosis. The Adaptix™ PEEK and the Capstone Control™ PEEK devices are to be used with autograft and/or allograft comprised of cancellous and/or corticocancellous bone graft and/or demineralized allograft bone with bone marrow aspirate. These implants are intended for use with supplemental fixation indicated for lumbar spinal fusion procedures and may be implanted via an open or a minimally invasive posterior approach and/or transforaminal approach. Materials: The Adaptix™ PEEK and Capstone Control™ PEEK implants are manufactured from polyetheretherketone (PEEK-OPTIMA® LT1) per ASTM F2026. The integral scaffold (OsteoSync) is manufactured from CP titanium (Grade 2) as described by ASTM F67. Marker pins in these lumbar devices are manufactured from tantalum per ASTM F560. Primary Predicate: Nano FortiCore® (Nanovis, LLC – K191822) Additional Predicate: Cascadia Interbody System (K2M, Inc. – K172009), Lumbar I/F Cage® (DePuy AcroMed Inc. – P960025), Capstone Control™ Spinal System (Medtronic Sofamor Danek USA, Inc. – K190165), Adaptix™ Interbody System with Titan nanoLOCK Surface Technology (Medtronic Sofamor Danek USA, Inc. – K201267)

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026